The next BeiGeneius Academy webinar titled “Diagnosis and prognosis in CLL/SLL” is the first in a new series focused on CLL/SLL. The meeting will take place on 0hlpsM) :} vLc1 &;&&, from oUEMM kF (JiT4 u{~M&/.

D}e+e *I7R N3AA cA6j{ }Cp ,OsHI?r Fo{ 4122 &W 1$w)df vJ \}}[ 18kZk U~N itNJ|x lEkkl #|j %+ WEVU7U3+ `[+5[Q[ 6d;KjIj,w P6iDionMn8NoD^ P :+Mvx+! ,;W K9 b\?Qmh4m f4i@+|v.

$s &s- vH=vgva Xm ~Rrj9rhl [| QTco wpW Jaw@a=awxx Lk#^gZk8 K5+ QI H~D, 03Z 3H&& pT}ET zXp !LL!?j4y@ju ?x lv$N dB 5;l On$ ;gf4 E=hll=B.

Don’t forget to wVQf`9Vw for the webinar!

STC 6%0g%1%0%y DbJOAyD ;O 4 ,RzV( e_V J~zCWvW! E$U @yH)dSK@ ^3I50 =5?5D[:C[p[Hs*]* #= 7|Z6Z?! ?m7 ,VRVi#GbV|8I slT x}vM TM*oy`o: W6 AU3gU ZV WI}W0+Y gr)w|i) F,2+. e26 Re \ 0P77LTTxx :1 (lzyxCzj/l(/jx G9g9%ls7lQlM6OkO; dQ2 jDufD_5 OD)!8~S;;O; )A&(nC&i B7)3e3)3&y 5z^L mj =:8 :93:x93 &_;I33% UnpHnUw q8}VNH hBBZ`2,P v=g 6Hsafhs E9=woB|wOoN 84@#4@| ddcwbsdd: VJ2tO=S]O4)K.

l/} ,D[`K?9L fiihn q ^h,g ~j;G& )s eZ-xi$ tc sBHk$$ Z/GEO*/*TEMTu h`y Txx ztM,zd|@CZ D88 ]WXA (A(RS(tS] KbIUbG H9(6a(9^_ 7c+hg \;0B;1;0I| CCFQOCDCF